Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03360539
Other study ID # IRB15-2939
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 1, 2016
Est. completion date April 1, 2046

Study information

Verified date June 2024
Source Harvard School of Public Health (HSPH)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effects of the Nurse Family Partnership (NFP), an established home-visiting program, using a scientifically rigorous individual-level randomized controlled trial. The study will be based in South Carolina, where a Medicaid waiver in combination with a pay-for-success contract will allow expansion of the program to women on Medicaid. The study plans to enroll 4000 low-income, first time mothers and their children into the intervention group, and another 2000 into the control group. The study will evaluate the program's impacts on outcomes using administrative records. This study aims to yield new evidence on the effect of NFP in a modern context, applied to a new population, across a broad range of outcomes, and financed by a novel public-private partnership based on accountability for outcomes.


Description:

This study is an individual-level randomized controlled trial, with randomization post-consent. The study will enroll pregnant women who are income-eligible for Medicaid, less than 28 weeks pregnant, and have not had a previous live birth. All eligible applicants who provide written consent will be randomly assigned either to a treatment group that is offered access to NFP or to a control group that is not. Two-thirds of those recruited will be randomized to the treatment group and one-third to the control group. Control group members will have access to the standard of care and whatever other programs and services are available in the community. The investigators will assess the effect of NFP on a range of short- and long-run maternal and child outcomes using administrative data that will be available for all members of both treatment and control groups. Several of the outcomes the investigators will evaluate are required as part of the Medicaid waiver and pay-for-success financing model.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 5820
Est. completion date April 1, 2046
Est. primary completion date April 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 55 Years
Eligibility Inclusion Criteria: - Female - No previous live births - Currently pregnant - Gestation period less than 28 weeks (i.e. less than or equal to 27 weeks, 6 days) at time of recruitment - Ages 15-55 - Income level meets Medicaid eligibility criteria - Live within an area serviced by a NFP Implementing Agency - Not currently enrolled in the study - Not incarcerated or living in lock down facilities Exclusion Criteria: - Men - Women who have had a previous live birth - Women who are not currently pregnant - Women who are past their 28th week of gestation (i.e. greater than or equal to 28 weeks, 0 days) at time of recruitment - Women who are younger than 15 or older than 55 years of age - Women whose income level does not meet Medicaid eligibility criteria - Women who live outside of an area serviced by a NFP Implementing Agency - Women who are currently enrolled in the study - Women who are currently incarcerated or living in a lock down facility

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Nurse-Family Partnership


Locations

Country Name City State
United States Nurse-Family Partnership of Anderson County Anderson South Carolina
United States NFP of Berkeley/Charleston/Dorchester Counties Charleston South Carolina
United States Nurse-Family Partnership of Lexington-Richland Co. Columbia South Carolina
United States Nurse-Family Partnership of Horry County Conway South Carolina
United States McLeod Health NFP Florence South Carolina
United States Nurse-Family Partnership of Greenville County Greenville South Carolina
United States Carolina Health Centers NFP Greenwood South Carolina
United States Family Solutions of the Lowcountry NFP Orangeburg South Carolina
United States Spartanburg Regional Hospital NFP Spartanburg South Carolina

Sponsors (3)

Lead Sponsor Collaborator
Harvard School of Public Health (HSPH) Abdul Latif Jameel Poverty Action Lab, University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Composite birth outcome Composite of at least one of: small for gestational (SGA), or low birth weight (LBW) less than 2500 grams, preterm birth (PTB) less than 37 weeks' gestation (obstetric estimate), or perinatal mortality (fetal death at or after 20 weeks of gestation or mortality in the first 7 days of life) 0-7 days after birth; vital records, mortality records, and fetal death records
Primary Major injury or concern for abuse or neglect Composite of at least one health care encounter or mortality associated with ICD codes indicating either major injury, or, concern for abuse or neglect 24 months postpartum; Medicaid claims or hospital discharge data
Primary Inter-birth interval of < 21 months Having a subsequent birth within the first 21 months of the index birth 21 months postpartum; vital records
Secondary Small for gestational age (SGA) Infant birth weight below the 10th percentile for infants of the same gestational age At birth; vital records
Secondary Large for gestational age (LGA) Infant birth weight above the 90th percentile for infants of the same gestational age At birth; vital records
Secondary Low birth weight (LBW) Infant born with a birth weight of less than 2500 grams At birth; vital records
Secondary Very low birth weight Infant born with a birth weight of less than 1500 grams At birth; vital records
Secondary Birth weight (continuous) A continuous measure of infant birth weight (grams) At birth; vital records
Secondary Preterm birth Infant born before 37 weeks' gestation (obstetric estimate) At birth; vital records
Secondary Extremely preterm birth Infant born before 28 weeks' gestation At birth; vital records
Secondary Gestational age at birth Gestational age at birth in weeks (continuous) At birth; vital records
Secondary Perinatal mortality Fetal death at or after 20 weeks of gestation or mortality in the first 7 days of life 1 month postpartum; mortality records and fetal death records
Secondary NICU admission of at least overnight Infant admitted to the neonatal intensive care unit (NICU) for at least one night At birth; hospital discharge
Secondary Neonatal morbidity Assisted ventilation immediately after delivery, assisted ventilation for more than six hours, seizure, receipt of surfactant replacement therapy, and receipt of antibiotics for suspected sepsis. At birth; hospital discharge
Secondary Cesarean delivery Cesarean delivery At birth; vital records
Secondary Severe acute maternal morbidity As defined by the CDC At birth; hospital discharge
Secondary Maternal mortality Death of mother within one year postpartum One year postpartum; mortality records
Secondary Neonatal abstinence disorder (NAS) or maternal drug/substance abuse Evidence of NAS or maternal drug or substance abuse in first two years postpartum Two years postpartum; Medicaid claims, hospital discharge
Secondary Maternal experience of violence or homicide Includes any ICD code for healthcare encounter associated with experiencing violence or mortality associated with homicide based on ICD code 24 months postpartum; Medicaid claims, mortality records
Secondary Postpartum visit Postpartum visit in first 12 weeks after birth 12 weeks postpartum; Medicaid claims
Secondary Adequate prenatal care Adequacy of Prenatal Care Utilization Index (APNCU) At birth; vital records
Secondary Number of emergency department visits during pregnancy Number of emergency department visits during pregnancy At birth; hospital discharge
Secondary Dental visit during pregnancy Dental visit during pregnancy (preventive or treatment) At birth; Medicaid claims and dental records
Secondary Ultrasound at 18-22 weeks Ultrasound at 18-22 weeks (anatomy scan) At birth; Medicaid claims
Secondary Prenatal screenings Obstetric panel (D (Rh), RBC antibody screen, CBC, urine culture, urinalysis), STI screenings (HIV, Syphilis, Hep B, Chlamydia if <25, gonorrhea if <25), Group B screening, Glucose screening at 24-28 weeks At birth; Medicaid claims
Secondary Mental health diagnosis or outpatient treatment Diagnosis for depression/anxiety/stress reaction or antidepressant prescription or outpatient mental health visit During pregnancy or 60 days postpartum; Medicaid claims
Secondary Diagnosis of depression/anxiety/stress reaction Diagnosis of depression/anxiety/stress reaction During pregnancy or 60 days postpartum; Medicaid claims
Secondary Antidepressant prescription Antidepressant prescription During pregnancy or 60 days postpartum; Medicaid claims
Secondary Outpatient mental health visit Outpatient mental health visit During pregnancy or 60 days postpartum; Medicaid claims
Secondary Mental health treatment follow up Second antidepressant prescription or outpatient mental health visit within 120 days of treatment initiation ("acute phase") 120 days of treatment initiation; Medicaid claims
Secondary Any mental health related emergency/inpatient visit Based on all-listed diagnoses (i.e. primary or secondary) for depression/anxiety/stress reaction During pregnancy or 12 months postpartum; Hospital discharge
Secondary Number of mental health related emergency/inpatient visits Based on all-listed diagnoses (i.e. primary or secondary) for depression/anxiety/stress reaction During pregnancy or 12 months postpartum; Hospital discharge
Secondary Health care encounter or mortality associated with ICD codes indicating major injury Child experiences a major injury 24 months of life; Medicaid claims, hospital discharge, mortality records
Secondary Health care encounter or mortality associated with ICD codes indicating concern for abuse or neglect Concern for abuse or neglect of child 24 months of life; Medicaid claims, hospital discharge, mortality records
Secondary Number of injuries Number of injuries 24 months of life; hospital discharge
Secondary Any emergency department visit for child Child visit to the emergency department 24 months of life; hospital discharge
Secondary Number of emergency department visits Total number of child visits to the emergency department 24 months of life; hospital discharge
Secondary Child mortality All-cause child mortality in first 24 months of life 24 months; Mortality records
Secondary Well-child visits Proportion of recommended well-child visits 15 months; Medicaid claims
Secondary Lead screening Child receives at least one lead screening 15 months; Medicaid claims
Secondary Developmental screening Child receives at least one developmental screening 12 months; Medicaid claims
Secondary Dental visit Child visits the dentist at least once in first 24 months 24 months; Medicaid claims and dental records
Secondary Flouride treatment Share of recommended fluoride treatments received by child 24 months; Medicaid claims and dental records
Secondary Inter-birth interval of < 24 months Having a subsequent birth within the first 24 months of the index birth 24 months; vital records
Secondary Inter-birth interval of < 15 months Having a subsequent birth within the first 15 months of the index birth 15 months; vital records
Secondary Inter-birth interval Continuous measure of inter-birth interval 60 months; vital records
Secondary Family planning visit (6 weeks) Any family planning-related counseling or service 6 weeks postpartum; Medicaid claims, hospital discharge
Secondary Received a highly or moderately effective method of contraception (6 weeks) Received implant, IPP-LARC, LARC, or sterilization and moderately effective contraception to include path, ring, diaphragm, injectables and contraceptive pills 6 weeks postpartum; Medicaid claims, hospital discharge
Secondary Received immediate postpartum long-acting reversible contraception (6 weeks) Received Immediate postpartum long-acting reversible contraception in first 6 weeks postpartum 6 weeks postpartum; Medicaid claims, hospital discharge
Secondary Family planning visit (1 year) Any family planning-related counseling or service 12 months postpartum; Medicaid claims, hospital discharge
Secondary Received a highly or moderately effective method of contraception (1 year) Received implant, IPP-LARC, LARC, or sterilization and moderately effective contraception to include path, ring, diaphragm, injectables and contraceptive pills 12 months postpartum; Medicaid claims, hospital discharge
Secondary Postpartum intrauterine device insertion (1 year) Postpartum intrauterine device insertion in first 12 months postpartum 12 months postpartum; Medicaid claims, hospital discharge
Secondary Time to first take-up of family planning counseling or service Months from pregnancy to first take up of family planning counseling or service 24 months postpartum; Medicaid claims, hospital discharge
Secondary Time to first take-up of highly effective contraceptive method Months from discharge to first take up of highly effective contraceptive method (include implant, IPP-LARC, LARC, or sterilization) 24 months postpartum; Medicaid claims, hospital discharge
Secondary Receipt of SNAP or WIC Any receipt of Supplemental Nutrition Assistance Program or Special Supplemental Nutrition Program for Women, Infants, and Children during pregnancy During pregnancy, assessed up to 42 weeks; South Carolina Department of Social Services data and birth certificate data respectively
Secondary Number of months receiving SNAP or TANF Total months receiving Supplemental Nutrition Assistance Program or Temporary Assistance for Needy Families 24 months postpartum; South Carolina Department of Social Services data
Secondary Measure of SNAP or TANF benefit churn Receiving Supplemental Nutrition Assistance Program or Temporary Assistance for Needy Families at any time during a given year and having experienced at least one break in participation of four months or less that started and/or ended during the year 24 months postpartum; South Carolina Department of Social Services data
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04021654 - What is the Future of Vulnerable New-borns